Search Videos and More
Rett Syndrome - a Multidisciplinary Approach
This presentation by Dr. Terry Grebe and Dr. Venode Narayanan outlines the multidisciplinary clinical management of Rett Syndrome (a neurodevelopmental disorder typically linked to MECP2 mutations) and explores emerging research, including the FDA-approved treatment trofinetide and experimental gene editing therapies.Recognition and Management of Metabolic Epilepsies
This video presents a clinically grounded overview of recent advances in neurogenetics and precision-based therapies for severe childhood-onset neurological disorders, including Dravet syndrome and related epileptic encephalopathiesA transposase-derived gene required for human brain development
A groundbreaking study published in Science Advances and featuring Phoenix Children’s investigators Michael Kruer, MD and Patricia Cornejo,, MD reveals a previously unknown requirement for somatic genetic diversity among neurons in normal brain development.Phoenix Children’s Designated a GLUT1 Deficiency Collaborative Care Network Site
Phoenix Children’s is officially a GLUT1 Deficiency Collaborative Care Network site, highlighting their expertise in rare neurological care and ketogenic diet therapy iAdvancing Pediatric Neuroscience: 2025 Innovation Report
The 2025 Innovation Report showcases a selection of the transformative initiatives undertaken over the past year. From pioneering clinical programs and cutting-edge research to novel therapeutic interventions, our multidisciplinary teams have worked relentlessly to address some of the most complex neurological conditions in pediatric medicine.Enhancing Precision in Pediatric Neurosurgery: Advanced Robotics Integration with LITT
Phoenix Children’s continues to advance minimally invasive neurosurgical techniques with the integration of advanced robotics into Laser Interstitial Thermal Therapy (LITT) proceduresSpotlight on Neuropsychology: An Integrated Approach to Pediatric Brain Health
Dr. Ashley Whitaker, Board-Certified Pediatric Neuropsychologist and Division Chief of Neuropsychology at Phoenix Children’s, leads a team that plays a vital role in the multidisciplinary care of children with neurological and medical complexities.Neurological Injury Paradigm Shifts in CHD Patients
While surgical survival for complex congenital heart disease (CHD) now exceeds 90%, over half of these children still develop significant neurological dysfunction.More than a White Matter Injury: Vulnerability of the Preterm Brain and Periventricular Leukomalacia (PVL)
Neonatologists have remarkably improved survival rates for low birth weight infants to approximately 90%First Awake Brain Surgery at Phoenix Children’s
Dr. Jason Hauptman performed Phoenix Children’s first ever Awake Craniotomy. Watch as Dr. Hauptman performs this procedure and discusses how it enables surgeons to operate more precisely and safely.Barrow Neurological Institute at Phoenix Children's 2024 Innovation Report
The 2024 Innovation Report highlights some of the transformative work accomplished over the past year. From groundbreaking clinical programs to cutting-edge research and novel therapeutic approaches, our multidisciplinary teams have worked tirelessly to address some of the most complex neurological disorders in children.Cerebral Vasculopathy in Neurofibromatosis Type 1: An Under-Recognized Problem?
Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by mutations in the NF1 gene, which encodes neurofibromin, a GTPase-activating protein (GAP)-related domain that negatively regulates the Ras/mitogen-activated protein kinase (RAS/MAPK) signaling pathway.